Proton beam therapy specialist Advanced Oncotherapy (AVO) has raised £5.9m through a placing and subscription for 14.8m shares at 40p per share. The move follows a £7.7m fundraise in October and will be used to progress the company’s next generation proton beam therapy system, LIGHT, which is due to become operational later this year. The placing was…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
 has raised £5.9m through a placing and subscription for 14.8m shares at 40p per share.){kind=link}